 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Board of Directors of Aarey Drugs & Pharmaceuticals Ltd at their Meeting held on today i.e 15th February, 2018 has allotted 10,00,000 (Ten Lacs) Convertible Warrants of Rs. 10/- (Rupee Ten Only) at a price of Rs. 92.60/- (Ninety Two Rupees and Sixty Paise) per Convertible Warrants (including a premium of Rs. 82.60/- per Convertible Warrants) on preferential basis to the Nimit R Ghatalia, Promoter.
Shares of AAREY DRUGS & PHARMACEUTICALS LTD. was last trading in BSE at Rs.51.7 as compared to the previous close of Rs. 53.9. The total number of shares traded during the day was 27092 in over 194 trades.
The stock hit an intraday high of Rs. 54.15 and intraday low of 50.75. The net turnover during the day was Rs. 1410424.